Loading
Bluelinea Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest was filed 21 Jul 2025.
Bluelinea: what insiders have been doing
Every trade that managers of Bluelinea disclose to AMF is tracked on this page. The company sits in the Healthcare & Pharma sector. The past year has been quiet: not a single insider filing for Bluelinea. The previous disclosure was published on 23 July 2025.
Our records for Bluelinea go back to 2023, with 2 purchases and 1 sale on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€290,749
2 ops. · all time
Sell Volume
€26,324
1 ops. · all time
Who traded when
BuySaleApicil Mutuelle Mutuelle1 buy
Apicil Prevoyance Institution de Prevoyance1 buy
Since the insiders bought
- -58.5%Entry €0.53 · Close at T+365 €0.22
- -58.5%Entry €0.53 · Close at T+365 €0.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Fundamental score
Ranked 21,012 of 24,158 companies
25.2
score / 100
Value22
Quality28
FCF yld-59%
Earn yld-51%
EV/EBITDA9.7x
ROE-71%
Gross mgn59%
Net mgn-14%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€0.14
Analyst consensus
Income statement
Revenue€10.7M
Gross profit€6.3M59% margin
EBITDA€645k6% margin
Net income-€1.5M-13.5% margin
Valuation
P/Book0.9x
Beta0.24
Balance sheet & cash
Market cap€2.9M
Total debt€3.3M
Free Cash Flow-€1.7M
Debt / Equity116%
Profitability & ownership
ROE-70.6%
ROA-8.7%
% insiders0.0%
% institutions65.1%
Last declaration on 23 July 2025
Declarations5 total
1,488,445 shares@ €0.5091.8% of flowActionSouscriptionISIN FR00110410112025DD1048846
4,543,548 shares@ €0.5091.0% of flowActionSouscriptionISIN FR00110410112025DD1048847
145,005 shares@ €0.468.2% of flowActionHors plateforme de négociationISIN FR00110410112025DD1048455
Canonical exit: 24 Sept 2025 (T+90)
487,059 shares@ €0.469.0% of flowActionHors plateforme de négociationISIN FR00110410112025DD1048457
Canonical exit: 8 Oct 2025 (T+90)
5,285 shares@ €4.9809100.0% of flowActionEuronext Growth ParisISIN FR00110410112023DD900969
5 of 5 declarations
About Bluelinea
Bluelinea is a French company focused on connected services and teleassistance, at the core of the Silver Economy. Listed on Euronext Growth Paris under the ticker ALBLU and identified by ISIN FR0011041011, the company was founded in 2006 and has gradually established itself as a leading player serving older adults, family caregivers and care facilities. Its positioning is based on a combination of technological innovation, 24/7 human support and solutions designed to improve independence, safety and quality of life for vulnerable users.
Historically, Bluelinea first built its business around home teleassistance through its HELP range, aimed at supporting ageing in place and reassuring families. The offering includes traditional teleassistance devices, fall-detection solutions, video-assisted teleassistance and mobile services for active seniors who want protection outside the home as well. The company emphasizes a round-the-clock response platform operating 24/7, with the ability to trigger help from relatives or emergency services depending on the situation.
Read moreShow less
In parallel, Bluelinea has developed a strong position in healthcare and long-term care facilities through SERENEA®, a wireless nurse-call and connected-equipment solution designed for nursing homes, assisted-living residences and other facilities caring for dependent people. The goal is twofold: improve resident safety and provide care teams with real-time coordination and operational management tools, thereby enhancing working conditions and day-to-day efficiency. The company states that it equips around 800 medico-social establishments and serves several tens of thousands of individual subscribers, which underlines a meaningful installed base in its domestic market.
On the ownership side, Groupe APICIL became the majority shareholder at the end of 2022, and its stake was further strengthened in 2025, making Bluelinea a strategically backed subsidiary of a major French mutual insurance group. This capital support has helped reinforce the company’s industrial and commercial path, while consolidating its role in the Silver Economy ecosystem, which Bluelinea has helped shape since the early public-policy initiatives dedicated to the sector. From a stock-market perspective, the company was first listed on Alternext in 2014 before moving to Euronext Growth Paris.
In 2025, Bluelinea reported consolidated revenue of EUR 10.271 million, up 9% year on year, driven by growth in the facilities-related business. This profile confirms a niche company positioned in a structurally attractive long-term market, while still facing the execution demands typical of an innovation-led, service-intensive business model.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
